SKB571

DRUG3 trials

Sponsors

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.

Conditions

HNSCCPancreatic CancerSolid Malignancies

Phase 1

A Phase 1 Study of SKB571 in Subjects With Advanced Solid Tumors

RecruitingNCT06725381

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.Solid Malignancies

Start: 2024-12-17End: 2027-12-01Target: 138Updated: 2026-05-08

Phase 2

A Phase II Study to Evaluate the Efficacy and Safety of SKB571 in Recurrent or Metastatic HNSCC Participants

RecruitingNCT07668154

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.HNSCC

Start: 2026-07-27End: 2028-12-31Target: 120Updated: 2026-09-09

A Multicenter, Open-label, Phase II Umbrella Study to Evaluate the Efficacy and Safety of the Investigational Product in Participants With Advanced or Metastatic Pancreatic Cancer

Not yet recruitingNCT07814066

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.Pancreatic Cancer

Start: 2026-10-31End: 2028-05-31Target: 30Updated: 2026-09-10